Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 4
2016 2
2017 2
2018 5
2019 10
2020 9
2021 19
2022 12
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of diagnostic accuracy between linked color imaging and autofluorescence imaging in patients with ulcerative colitis: A prospective observational study.
Sugiyama Y, Takahashi K, Sasaki T, Ueno N, Watanabe H, Iribe K, Sekiguchi S, Tachibana S, Kobayashi Y, Ando K, Kashima S, Moriichi K, Tanabe H, Yuzawa S, Fujiya M. Sugiyama Y, et al. Among authors: ando k. J Gastroenterol Hepatol. 2024 Apr 27. doi: 10.1111/jgh.16586. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38676457
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Among authors: ando k. Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18013. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38651779
The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study.
Ueno N, Saito S, Sato M, Sugiyama Y, Kobayashi Y, Murakami Y, Sugimura K, Sasaki T, Sakatani A, Takahashi K, Tanaka K, Serikawa S, Ando K, Kashima S, Muto M, Inaba Y, Moriichi K, Tanabe H, Okumura T, Fujiya M. Ueno N, et al. Among authors: ando k. Ther Apher Dial. 2024 Jun;28(3):442-452. doi: 10.1111/1744-9987.14103. Epub 2024 Jan 2. Ther Apher Dial. 2024. PMID: 38168492
Effectiveness and Factors Associated with Response to Golimumab in Japanese Patients with Ulcerative Colitis in Real Clinical Practice: The Phoenix Study.
Hirayama D, Motoya S, Ashida T, Ando K, Fujiya M, Ito T, Furukawa S, Maemoto A, Katsurada T, Hinotsu S, Sato N, Mizuno N, Ikawa Y, Nakase H. Hirayama D, et al. Among authors: ando k. Inflamm Intest Dis. 2023 Aug 31;8(3):115-127. doi: 10.1159/000533871. eCollection 2023 Dec. Inflamm Intest Dis. 2023. PMID: 38098492 Free PMC article.
Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn's disease in Japan (SPREAD-J study).
Sakurai T, Omori T, Tanaka H, Ito T, Ando K, Yamamura T, Nanjjo S, Osawa S, Takeda T, Watanabe K, Hiraga H, Yamamoto S, Ozeki K, Tanaka S, Tajiri H, Saruta M; SPREAD-J group. Sakurai T, et al. Among authors: ando k. J Gastroenterol. 2023 Oct;58(10):1003-1014. doi: 10.1007/s00535-023-02017-3. Epub 2023 Jul 21. J Gastroenterol. 2023. PMID: 37479808 Free PMC article.
The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report.
Sugiyama Y, Ueno N, Tachibana S, Kobayashi Y, Murakami Y, Sasaki T, Sakatani A, Takahashi K, Ando K, Kashima S, Moriichi K, Tanabe H, Okumura T, Fujiya M. Sugiyama Y, et al. Among authors: ando k. Medicine (Baltimore). 2023 Jul 14;102(28):e34331. doi: 10.1097/MD.0000000000034331. Medicine (Baltimore). 2023. PMID: 37443475 Free PMC article.
71 results